Developed countries shift narrative raising questions on safety and efficacy issues around drugs As images of the elderly […]
Category Archive: WHO
THE NEED FOR REGULATORY COHERENCE: LESSONS FROM REMDESIVIR The story of Gilead’s drug remdesivir, one of the earliest […]
TRIPS WAIVER: THE NEEDLE HAS MOVED, BUT THE FIGHT IS ON EU bloc and others, push for TRIPS […]
The World Health Assembly draws all member states of World Health Organization to discuss health challenges, review actions, […]
The U.S. and Brazil have teamed up to lay out a governance reform proposal for WHO in the […]
The 73rd World Health Assembly resumes virtually next week at a time when large parts of Europe including […]
Sridhar Venkatapuram, is an Associate Professor at the Global Health Institute, King’s College London. He has spearheaded the Independent […]
A SHORT BLOG: Questions are beginning to emerge as to why WHO proceeded to give a prequalification listing to […]
INSIDE COVAX: CONTRACTS & GOVERNANCE A closer look at the model contracts issued by the COVAX Facility and […]
COUNTRIES WANT WHO TO CONSULT MORE: EXECUTIVE BOARD MEETING Countries praise WHO efforts on addressing the pandemic, but […]